Cc1cc(N2CCN(Cc3nc(-c4ccc(F)cc4)oc3C)CC2)cc(C)n1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?